Evidence map›Paper›PMID 28607663›Full record

ArticleElectronic physician2017

The structure of the pharmaceutical market in Iran using concentration indices.

Mohammad Mohseni, Hasan Abolghasem Gorji, Bahman Ahadinezhad, Omid Khosravizadeh, Meysam Safi Keykaleh, Ahmad Moosavi, Bahareh Mohtashamzadeh

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Electronic physician, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mohammad MohseniHealth Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.
Hasan Abolghasem GorjiSchool of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.
Bahman AhadinezhadDepartment of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Omid KhosravizadehSocial Determinants of Health Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.
Meysam Safi KeykalehSchool of Health, Safety and Environment, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Ahmad MoosaviDepartment of Health and Community Medicine, Dezful University of Medical Sciences, Dezful, Iran.
Bahareh MohtashamzadehSchool of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectiveThe efficiency and function of the pharmaceutical sector, as a vital portion of the health system, have a significant effect on intermediate and final indices of health. In this research, the structure of the pharmaceutical market in Iran was examined through the calculation of concentration indices in 2011.

methodsIn this cross-sectional study, the needed data was gathered from the Food and Drug Administration in the year 2011. Data were analyzed using SPSS software version 20 and Microsoft Office Excel software. Finally, two common measures of market concentration, the Concentration Ratio and the Herfindahl-Hirschman Index, were calculated.

resultsThe largest and the smallest shares of the industry were 5.57% and 0.01%, respectively. The average industry share was 1.09%. The share range was calculated to be 5.56%. The Herfindahl-Hirschman Index was 248.5, which indicates a very low concentration of the pharmaceutical market in Iran. Also, based on the Concentration Ratio of 4 companies (18.39%), the concentration of the pharmaceutical market has been too low.

conclusionThe pharmaceutical market in Iran has a very low concentration and it does not have an exclusive mode in terms of market structure. Therefore, it can be attributed to the competitive model. The policy makers in this area can use this characteristic as a leverage to improve efficiency, fairness, revenue and health indices.

Indexed as

ConcentrationDrugIndexIranPharmaceutical Market

Identifiers

PMID28607663
PMCPMC5459300

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.